EP
EW icon

Eudaimonia Partners’s Edwards Lifesciences EW Stock Holding History

Eudaimonia Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$312K Buy
2,756
+614
+29% +$70.1K 0.06% 301
2021
Q2 		$222K Buy
2,142
+187
+10% +$17.6K 0.04% 353
2021
Q1 		$164K Buy
1,955
+105
+6% +$8.88K 0.03% 375
2020
Q4 		$168K Sell
1,850
-4
-0.2% -$332 0.04% 340
2020
Q3 		$148K Buy
1,854
+720
+63% +$56.2K 0.04% 329
2020
Q2 		$78K Sell
1,134
-804
-41% -$57.1K 0.03% 413
2020
Q1 		$122K Sell
1,938
-105
-5% -$7.57K 0.05% 297
2019
Q4 		$159K Buy
+2,043
New +$160K 0.06% 273

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Eudaimonia Partners's EW Position: Q3 2021 in Review

Eudaimonia Partners increased its Edwards Lifesciences (EW) stake by 29% in Q3 2021, buying an estimated $70.1K and bringing the position to 2,756 shares worth $312K. The position accounts for 0.06% of the portfolio, ranked #301.

Eudaimonia Partners first reported a position in EW in Q4 2019 and has held it in 8 quarters since. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • Eudaimonia Partners held 2,756 shares of Edwards Lifesciences worth $312K as of Q3 2021.
  • Eudaimonia Partners bought 614 Edwards Lifesciences shares in Q3 2021, an estimated $70.1K.
  • Edwards Lifesciences made up 0.06% of Eudaimonia Partners's portfolio in Q3 2021, its #301 holding.
  • Eudaimonia Partners first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 8 quarters since.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.